DK1084143T3 - Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt - Google Patents

Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt

Info

Publication number
DK1084143T3
DK1084143T3 DK99924806T DK99924806T DK1084143T3 DK 1084143 T3 DK1084143 T3 DK 1084143T3 DK 99924806 T DK99924806 T DK 99924806T DK 99924806 T DK99924806 T DK 99924806T DK 1084143 T3 DK1084143 T3 DK 1084143T3
Authority
DK
Denmark
Prior art keywords
product
mbl
virus
purification process
mannan
Prior art date
Application number
DK99924806T
Other languages
English (en)
Inventor
Inga Laursen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of DK1084143T3 publication Critical patent/DK1084143T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
DK99924806T 1998-06-10 1999-06-10 Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt DK1084143T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK79398 1998-06-10
US10100798P 1998-09-18 1998-09-18
PCT/DK1999/000319 WO1999064453A1 (en) 1998-06-10 1999-06-10 Purification process for production of mannan-binding lectin and an mbl medicinal product

Publications (1)

Publication Number Publication Date
DK1084143T3 true DK1084143T3 (da) 2006-12-27

Family

ID=26064673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99924806T DK1084143T3 (da) 1998-06-10 1999-06-10 Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt

Country Status (9)

Country Link
EP (1) EP1084143B1 (da)
AT (1) ATE336504T1 (da)
AU (1) AU764066B2 (da)
CA (1) CA2334696C (da)
DE (1) DE69932817T2 (da)
DK (1) DK1084143T3 (da)
ES (1) ES2272067T3 (da)
NZ (1) NZ509089A (da)
WO (1) WO1999064453A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100497849B1 (ko) 1997-08-21 2005-06-29 다카라 바이오 가부시키가이샤 제암제
DE60009896T2 (de) 1999-05-14 2005-04-21 Steffen Thiel Neue indikationen für mannan-binding lectin (mbl) zur behandlung von immungeschwächten patienten
EP1303288A1 (en) * 2000-07-13 2003-04-23 Natimmune A/S Mannan-binding lectin (mbl) treatment of infections in individuals treated with tnf-alfa inhibitors
US20040192589A1 (en) 2001-07-23 2004-09-30 Finn Matthiesen Production of high molecular mass lectins
WO2003018617A1 (fr) * 2001-08-31 2003-03-06 Fuso Pharmaceutical Industries, Ltd. Procede de purification de lectine liant le mannose humain, compositions de lectine liant le mannose humain et utilisation medicale de la lectine liant le mannose humain
DK1344533T3 (da) * 2002-03-15 2007-01-08 Natimmune As Farmaceutiske præparater, der omfatter mannosebindende lectin
CN1646152A (zh) * 2002-04-24 2005-07-27 昆士兰医学研究学院理事会 甘露糖结合凝集素及其应用
GB0222014D0 (en) * 2002-09-23 2002-10-30 Leuven K U Res & Dev Mannan-binding lectin
WO2006035024A1 (en) * 2004-09-29 2006-04-06 Mellitus, S.L. Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease
EP1888208B1 (en) 2004-10-21 2012-11-14 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein

Also Published As

Publication number Publication date
DE69932817T2 (de) 2007-03-15
CA2334696C (en) 2014-03-25
DE69932817D1 (de) 2006-09-28
AU764066B2 (en) 2003-08-07
EP1084143B1 (en) 2006-08-16
NZ509089A (en) 2002-10-25
EP1084143A1 (en) 2001-03-21
ATE336504T1 (de) 2006-09-15
AU4134399A (en) 1999-12-30
CA2334696A1 (en) 1999-12-16
WO1999064453A1 (en) 1999-12-16
ES2272067T3 (es) 2007-04-16

Similar Documents

Publication Publication Date Title
DK1084143T3 (da) Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
AU2671795A (en) Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
NO308029B1 (no) Inhibitorer av <beta>-amyloidproteinproduksjon og farmasøytisk preparat inneholdende disse
UA27085C2 (uk) Спосіб отримаhhя силдеhафілу та проміжhі сполуки
HK1013806A1 (en) Antibody purification
PE15297A1 (es) Proteinas anti-obesidad
UA99263C2 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТОГО БЕЛКА
TW200505939A (en) Process for production of cyclic peptides
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
NO20011891L (no) Anvendelse av radioligander for screening av inhibitorer av amyloid-<beta>-peptid produksjon
ES2078947T3 (es) Purificacion del complejo del factor viii utilizando cromatografia de afinidad con heparina.
WO2002101021A3 (en) Purification of human serum albumin
Guillén-Chable et al. Antibacterial activity and phospholipid recognition of the recombinant defensin J1-1 from Capsicum genus
WO2007063129A3 (en) Insolation of peptides , polypeptides and proteins
NO20005152D0 (no) Human protease og anvendelse av slik protease for farmasøytiske anvendelser og for reduksjon av allergenisiteten til ikke-humane proteiner
Ueda et al. Ni (II)-based immobilized metal ion affinity chromatography of recombinant human prolactin from periplasmic Escherichia coli extracts
DK0419878T3 (da) Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form
DE50011920D1 (de) Direkt verpressbarer rohstoff für komprimate
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
ATE349531T1 (de) Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung
CA2002833A1 (en) Interferon-gamma binding proteins
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
WO2002006464A3 (en) Large scale expression and purification of recombinant proteins
NO20051938L (no) Promoter til IL-18BP, dens fremstilling og anvendelse